A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition ; volume:8 ; number:1 ; day:5 ; month:1 ; year:2024 ; pages:1-10 ; date:12.2024
npj precision oncology ; 8, Heft 1 (5.1.2024), 1-10, 12.2024
- Urheber
-
Lenchner, Daniel S.
Petrova, Zaritza O.
Hunihan, Lisa
Ashtekar, Kumar D.
Walther, Zenta
Wilson, Frederick H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41698-023-00490-w
- URN
-
urn:nbn:de:101:1-2024031821170331412936
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lenchner, Daniel S.
- Petrova, Zaritza O.
- Hunihan, Lisa
- Ashtekar, Kumar D.
- Walther, Zenta
- Wilson, Frederick H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hypoglycemia-activated Hypothalamic Microglia Impairs Glucose Counterregulatory Responses
Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma
Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)
Bedeutung der Mitogen Activated Protein Kinase Activated Protein Kinase 2 (MK2) für die Regulation von Hepcidin
Predicting EGFR mutation, ALK rearrangement, and uncommon EGFR mutation in NSCLC patients by driverless artificial intelligence: a cohort study
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization
HER2/neu, EGFR und c-Met-Mutation/ Amplifikation
Targeting pyruvate dehydrogenase kinase 1 overcomes EGFR C797S mutation-driven osimertinib resistance in non-small cell lung cancer
Mitogen-Activated Protein Kinase-Activated Protein Kinase 2-Deficient Mice Show Increased Susceptibility to Listeria monocytogenes Infection
EGFR tyrosine kinase activity and Rab GTPases coordinate EGFR trafficking to regulate macrophage activation in sepsis
Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
Hypoglycemia-activated Hypothalamic Microglia Impairs Glucose Counterregulatory Responses
Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma
Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)
Bedeutung der Mitogen Activated Protein Kinase Activated Protein Kinase 2 (MK2) für die Regulation von Hepcidin
Predicting EGFR mutation, ALK rearrangement, and uncommon EGFR mutation in NSCLC patients by driverless artificial intelligence: a cohort study
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization
HER2/neu, EGFR und c-Met-Mutation/ Amplifikation
Targeting pyruvate dehydrogenase kinase 1 overcomes EGFR C797S mutation-driven osimertinib resistance in non-small cell lung cancer
Mitogen-Activated Protein Kinase-Activated Protein Kinase 2-Deficient Mice Show Increased Susceptibility to Listeria monocytogenes Infection
EGFR tyrosine kinase activity and Rab GTPases coordinate EGFR trafficking to regulate macrophage activation in sepsis
Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
Hypoglycemia-activated Hypothalamic Microglia Impairs Glucose Counterregulatory Responses
Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma
Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5)
Bedeutung der Mitogen Activated Protein Kinase Activated Protein Kinase 2 (MK2) für die Regulation von Hepcidin
Predicting EGFR mutation, ALK rearrangement, and uncommon EGFR mutation in NSCLC patients by driverless artificial intelligence: a cohort study
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization
HER2/neu, EGFR und c-Met-Mutation/ Amplifikation
Targeting pyruvate dehydrogenase kinase 1 overcomes EGFR C797S mutation-driven osimertinib resistance in non-small cell lung cancer
Mitogen-Activated Protein Kinase-Activated Protein Kinase 2-Deficient Mice Show Increased Susceptibility to Listeria monocytogenes Infection
EGFR tyrosine kinase activity and Rab GTPases coordinate EGFR trafficking to regulate macrophage activation in sepsis
Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients